BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

Overview

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is the #10 most commonly reported adverse reaction for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 573 FDA adverse event reports linking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE to WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. This represents approximately 2.5% of all 23,211 adverse event reports for this drug.

Patients taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE who experience wrong technique in product usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is a less commonly reported adverse event for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, but still significant enough to appear in the safety profile.

Other Side Effects of BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE

In addition to wrong technique in product usage process, the following adverse reactions have been reported for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE:

• DYSPNOEA — 1,670 reports
• DEVICE DELIVERY SYSTEM ISSUE — 1,350 reports
• PRODUCT DOSE OMISSION ISSUE — 1,097 reports
• WRONG TECHNIQUE IN DEVICE USAGE PROCESS — 1,087 reports
• DEATH — 1,079 reports
• DEVICE USE ISSUE — 1,019 reports
• INCORRECT DOSE ADMINISTERED BY DEVICE — 732 reports
• DEVICE MALFUNCTION — 667 reports
• COUGH — 657 reports
• DRUG INEFFECTIVE — 541 reports

Other Drugs Associated with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

The following drugs have also been linked to wrong technique in product usage process in FDA adverse event reports:

Does BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE cause WRONG TECHNIQUE IN PRODUCT USAGE PROCESS?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS has been reported as an adverse event in 573 FDA reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN PRODUCT USAGE PROCESS with BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS accounts for approximately 2.5% of all adverse event reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, making it a notable side effect.

What should I do if I experience WRONG TECHNIQUE IN PRODUCT USAGE PROCESS while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE?

If you experience wrong technique in product usage process while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages